Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolismJean‐Charles Lambert, Elaine R. Peskind, John Q. Trojanowski et al.|Acta Neuropathologica|2016Cited by 78
High‐Content Screening of Synaptic Density Modulators in Primary Neuronal CulturesAudrey Coulon, Julien Chapuis, Anne‐Marie Ayral et al.|Current Protocols|2023Cited by 3